#Oncology

Treeline Biosciences Raises $200M, Initiates Clinical Trials

The company also initiated Phase 1 trials for three oncology programs, including a pan-KRAS inhibitor.

Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01

Breakthrough Discovery by Cancer 3D Shows Tumors Behave as Invasive Networks

RISA Labs Raises $3.5M to Eliminate Treatment Delays with AI-Powered Workflow Automation in Oncology

Pangea Biomed Extends Seed Round by $5 Million for its Multi-Cancer Response Predictor Technology